Benzinga | Jan 31, 2022 09:15AM EST

Oppenheimer Upgrades Insulet to Outperform, Lowers Price Target to $275

Oppenheimer analyst Steven Lichtman upgrades Insulet (NASDAQ:PODD) from Perform to Outperform and lowers the price target from $300 to $275.